Moderna Inc. stock skyrocketed in the extended session Tuesday after the biotech company said its coronavirus vaccine candidate produced a œrobust immune-system response in a larger group of people and the study will move to a decisive clinical trial in July.
Results published in The New England Journal of Medicine showed that a two-dose vaccination schedule induced the desired immune response in all 45 people evaluated, a larger group than in the preliminary data Moderna MRNA, +4.54% released in May, and was generally safe and well-tolerated, the company said.
Shares of Moderna ended the regular trading day up 4.5%. The company is a front-runner among several developing experimental COVID-19 vaccines.
The results œreaffirm the positive interim data released back in May, Moderna said. The trial vaccine œinduced rapid and strong immune responses against SARS-CoV-2, the coronavirus that causes COVID-19.
No serious adverse effects were reported, but some that did occur, such as headaches and fatigue, were œgenerally transient and mild to moderate in severity, the company said.
Moderna is evaluating whether the participants™ immune responses are lasting, with participants followed for one year.
Source : Marketwatch
The United States on Tuesday accused companies in the United Arab Emirates, the Central African Republic and Russia of engaging in illicit gold deals to help fund the mercenary fighters of Russia's Wa...
The United States is providing up to $500 million in additional military aid for Ukraine, three U.S. officials tell VOA, in a package that is expected to include 55 more Stryker and Bradley armored ve...
The United States said Sunday that the brief rebellion of mercenary leader Yevgeny Prigozhin against Russia's military leadership shows "very serious cracks" in the two-decade rule of President Vladim...
US President Joe Biden pressed the forces of democracy on Thursday (22/6) while receiving Indian Prime Minister Narendra Modi's state visit at the White House. He praised the two countries' collaborat...
The United States is "deeply concerned" about the escalation in violence in the West Bank, a US State Department spokeswoman said, adding that reports of an Israeli attack on a Palestinian village Wed...
Nikkei Japanese stocks rose, erasing early losses to eke out gains as value stocks such as financials were buoyed by Berkshire Hathaway Inc.'s bumper yen bond sale raising hopes of more investment from the Omaha-based firm. The Topix Index rose...
The S&P 500 slipped for a fifth straight day on Thursday, placing the benchmark on track for its longest losing streak this year. The broad index lost 0.3%, while the Nasdaq Composite dropped 0.6%. The Dow Jones Industrial Average added 58...
West Texas Intermediate (WTI) crude oil closed higher on Thursday, posting a small gain following three losing sessions that came as the geopolitical risk premium eased while rising US inventories are seen as a signal of weak demand. WTI crude oil...
Federal Reserve (Fed) Chairman Jerome Powell participates in a fireside chat about economic trends in North America at the Wilson Center's...
Asia-Pacific markets extended their declines as the world awaits Israel's response to Iran's air assault over the weekend.
On Tuesday, China's...
New home construction in the US slowed last month as consumers try to wait out high mortgage rates in hopes borrowing costs will ease later this...
China's economic momentum showed signs of cooling in March after a strong start in the first two months of the year, official data showed...